Cyclophosphamide Interactions
There are 406 drugs known to interact with cyclophosphamide, along with 6 disease interactions. Of the total drug interactions, 59 are major, 318 are moderate, and 29 are minor.
- View all 406 medications that may interact with cyclophosphamide
- View cyclophosphamide disease interactions (6)
Most frequently checked interactions
View interaction reports for cyclophosphamide and the medicines listed below.
- Adriamycin (doxorubicin)
- Ativan (lorazepam)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Compazine (prochlorperazine)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Emend (aprepitant)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Lasix (furosemide)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Neulasta (pegfilgrastim)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- Rituxan (rituximab)
- Taxotere (docetaxel)
- Tylenol (acetaminophen)
- Velcade (bortezomib)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Cyclophosphamide disease interactions
There are 6 disease interactions with cyclophosphamide which include:
- myelosuppression
- urinary tract obstruction
- cardiac disease/cardiotoxicity
- hepatic dysfunction
- pulmonary impairment
- renal dysfunction
Report options
More about cyclophosphamide
- cyclophosphamide consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
